MAP Pharmaceuticals Inc (MAPP) said on Tuesday its experimental orally inhaled migraine drug reached all four goals of a late-stage clinical study, and its shares more than doubled. Be sure to put MAPP in the free analysis tool below to get a free report sent to your in-box.
Uptrend
MAP PHARMACEUTICALS INC (MAPP)
Based on a pre-defined weighted trend formula for chart analysis, MAPP scored +75 on a scale from -100 (strong downtrend) to +100 (strong uptrend):
FREE Trend analysis for MAPP Here
Trend Analysis is a daily email analysis tool that gives me insight into exactly what my portfolio is doing. This link takes you to get your first symbol analyzed and from there you can easily add more symbols to get a daily update, which I find very helpful. There are only a few quality sites out there that provide FREE high quality trading tools.
